MSR19 A Matching-Adjusted Indirect Comparison of Asciminib Versus Ponatinib, Nilotinib and Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients after ≥2 Tyrosine Kinase Inhibitors
作者
EL Atallah,Vikalp Kumar Maheshwari,MJ Mauro,Carla Maria Boquimpani,Delphine Réa,Andreas Hochhaus,Yosuke Minami,Lovneet Saini,Regina Corbin
出处
期刊:Value in Health [Elsevier BV] 日期:2022-06-25卷期号:25 (7): S521-S521